HOW PROTEIN ARRAYS IMPROVE CANCER THERAPEUTICS?

Cancer is a complex degenerative disease needing for rapid and precise diagnosis. Cancer disease is characterized by heterogeneous and changing phenotypes continuously progressing through different clinical stages. As a global approach, personalized medicine aims at integrating diagnosis with therapy. To do so, it is necessary to get as much information as possible about patient genetics…

Mapix v9.0.0 released

Mapix software manages microarray image acquisition and analysis. Version 9.0.0 includes the gridding of rectangular and square features in addition to the classical circular spots. In order to address user’s requirements in the analysis of high density peptide arrays, Mapix is now able to manage global background calculation, based on an area defined by the…

FLUORESCENCE IMAGING: WHAT IS IT?

The English physicist George Gabriel Stokes coined the term fluorescence in 1852. He observed blue light emitted by fluorite crystals (calcium fluoride) illuminated by ultraviolet light. Even if the emission was related to impurities in the crystals, the term ‘fluorite’ inspired Stokes to name this phenomenon.   The biological and biomedical sciences use fluorescence physical…

ANTIMICROBIAL RESISTANCE AND NOVEL DRUGS DISCOVERY

Glycan arrays are efficient tools leading to the discovery of therapeutic strategies. InnoScan analyses of glycan arrays enable to identify specific glycan interactions. With the development of antibiotic resistance, infections are harder to treat. According to the WHO, antimicrobial resistance is one of the current global health threat. Therefore, it is urgent to find novel…